Search results
3 No-Brainer Stocks to Buy in May
Motley Fool via Yahoo Finance· 1 hour agoAnother massive market could open up to Vertex soon. The company recently submitted the first module of its rolling U.S. regulatory submission of...
These Are the Drugs America Is Running Short On
247wallst.com· 6 days agoDrug shortages in America are the result of supply line challenges, profit-based operations, and company closures.
Inside the secret plan to bring back John Galliano – fashion’s most controversial designer
The Telegraph via Yahoo News· 1 hour agoThe word around Paris is that John Galliano, the British fashion designer who was arrested in 2011...
Pharmaceutical giants knowingly sold HIV-infected treatment to NHS
The Telegraph via Yahoo News· 17 hours agoAfter Dr Peter...haemophilia centre in Newcastle, told Armour four patients had tested positive for...
Why Cannabis Companies Tilray, Canopy Growth, Cronos, and SNDL Got Really High on Tuesday
Motley Fool via Yahoo Finance· 5 days agoBut perhaps the most onerous headwind that will be reversed by rescheduling is...companies will no...
Senator slams drugmaker for seeming to skirt pledge to cap inhaler cost
The Hill· 3 days agoDrug manufacturing giant GlaxoSmithKline (GSK) is subverting its pledge to lower the price of its...
Why Weight-Loss Drugs Wegovy, Zepbound Are in Short Supply
The Business of Fashion· 3 days agoShortages have left patients already on the medications searching for their next dose and stymied...
Is “The Fall Guy” OK for Kids? What to Know Before Seeing the PG-13 Action-Comedy
People via Yahoo News· 2 days agoAssisted by stunt doubles who take brutal punches, drive obscenely fast and fall from awe-inspiring...
TIME100 Health: David Ricks
Time via AOL· 3 days agoDavid Ricks Credit - David Paul Morris—Bloomberg/Getty Images It’s hard for a major pharmaceutical company to launch one successful novel drug& ...
Mendez: Price caps on inhalers won’t do enough
Boston Herald· 1 day agoPresident Biden recently held an event to celebrate that three major drugmakers announced they are putting a $35 monthly out-of-pocket price cap on...
